CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 637 enrolled
Drug / intervention
Decision aidbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05376241
NCT05376241Phase 2Completed
CompareCT.gov

Understanding Affective Processing of Scientific Evidence to Promote Informed Choice for Breast Cancer Screening

University of Colorado, Denver·interventional·Posted May 17, 2022·Updated Mar 27, 2026

In Brief

A Phase 2 clinical trial evaluating Decision aid for Breast Cancer. Completed, enrolled 637 participants across 1 site.

Detailed Summary

Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
20222023202420252026
First PostedMay 17, 2022
Enrollment StartJan 3, 2022
Primary CompletionMay 7, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.1 years ago

Interventions

Decision aidbehavioral

Mammography screening decision aid for women in their 40s with information about screening guidelines, breast cancer mortality reduction, false positives, overdiagnosis, and a personal breast cancer risk estimate.